Skip to main navigation
Skip to search
Skip to main content
the University of Groningen research portal Home
Help & FAQ
English
Nederlands
Home
Profiles
Research units
Research output
Activities
Datasets
Press/Media
Projects
Prizes
Search by expertise, name or affiliation
Coagulation factor VIIa: prohemostatic drug and biomarker for thrombosis
Anne Marieke Schut
Groningen Institute for Organ Transplantation (GIOT)
Research output
:
Thesis
›
Thesis fully internal (DIV)
1812
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Coagulation factor VIIa: prohemostatic drug and biomarker for thrombosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Thrombosis
100%
Coagulation Factor VII
100%
Recombinant
80%
Venous Thrombosis
20%
Coagulation
20%
Risk Factors
10%
Possible Mechanisms
10%
4-fold
10%
Platelets
10%
Hemophilia
10%
Clinical Effect
10%
Complex Disease
10%
Blood Coagulation
10%
Bleeding
10%
Factor VIII (FVIII)
10%
Hemostatic Effect
10%
Coagulation Factors
10%
Prophylactic Effect
10%
Hemophilia Patients
10%
Air Travel
10%
Once-daily Administration
10%
FVIIa
10%
VIIa
10%
Inhibitory Antibody
10%
Acute Venous Thrombosis
10%
Physiological Activation
10%
Venous Thrombus
10%
Medicine and Dentistry
Biological Marker
100%
Thrombosis
100%
Blood Clotting Factor
100%
Phlebothrombosis
30%
Disease
10%
Supplementation
10%
Bleeding
10%
Thrombus
10%
Platelet
10%
Haemophilia
10%
Hemostat
10%
Blood Clotting
10%
Factor VII
10%
Patient with Hemophilia
10%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Blood Clotting Factor
100%
Thrombosis
100%
Vein Thrombosis
30%
Haemophilia
20%
Disease
10%
Bleeding
10%
Thrombus
10%
Hemostatic Agent
10%
Blood Clotting Factor 7
10%
Immunology and Microbiology
Blood Plasma
100%
Monospecific Antibody
100%
Platelet
100%
Blood Clotting
100%